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Childhood neurodevelopmental disorders have been attributed to several prenatal 
factors, including maternal diets (Madore et al., 2014) and maternal inflammation (Estes & 
McAllister, 2016; Patterson, 2009) during pregnancy. A report in this issue of Brain, 
Behavior, and Immunity used animal models to examine the protective effects of dietary 
omega-3 polyunsaturated fatty acids (n-3 PUFAs) during pregnancy on brain development of 
the offspring, in the context of environmental adversity such as maternal inflammation 
(Labrousse et al., 2018). Previous study showed that lower amount of maternal seafood 
intake, comprising of n-3 PUFAs, during pregnancy has been associated with suboptimal 
social developmental, fine motor, prosocial behavior and communication outcomes in the 
offspring (Hibbeln et al., 2007). Moreover, maternal n-3 PUFAs levels have been inversely 
associated with pro-inflammatory cytokine levels in women with perinatal depression 
(Chang, Lin, et al., 2018), and perinatal depression has been associated with poor 
developmental outcomes of the child (Kingston et al., 2018), and even increased the risk for 
depression as adults (Plant, Pariante, Sharp, & Pawlby, 2015). In addition, n-3 PUFAs 
deficiency has been associated with several neurodevelopmental disorders, including 
attention deficit hyperactivity disorder, autism and schizophrenia (Chang, Su, Mondelli, & 
Pariante, 2018; Maekawa et al., 2017; Mazahery et al., 2017). PUFAs are essential fatty acids 
with immunomodulatory properties (Calder, 2005) and can only be obtained from the diet. N-
3 PUFAs, including docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), favor 
anti-inflammatory responses, while omega-6 PUFAs promotes pro-inflammatory actions 
(Calder, 2006). However, the association between n-3 PUFAs deficiency, in the context of 
maternal inflammation during pregnancy, and the neurodevelopmental outcomes in the 
offspring still require further investigation. On the basis of human epidemiological findings, a 
number of translational rodent models have been established to help provide insight into such 
relationship by exploring the consequences of maternal immune activation (MIA) during 
pregnancy on brain and behavioral development. In the current animal models of in utero 
inflammation, including MIA, pregnant animals are exposed to an immunological 
manipulation at a specific gestational stage. The immunological manipulation includes 
exposure to immunogens such as human influenza virus, the viral mimic- polyriboinosinic-
polyribocytidilic acid, the bacterial endotoxin lipopolysaccharide (LPS), the locally acting 
inflammatory agent turpentine, or selected inflammatory cytokines. The MIA models are 
important in identifying the causal mechanisms that affect normal brain development in the 
event of early-life immune exposures. MIA has been associated with altered connectivity in 
the brain structures of neonates and toddlers (Spann, Monk, Scheinost, & Peterson, 2018), 
and has been suggested as a risk factor for neurodevelopmental disorders (Solek, Farooqi, 
Verly, Lim, & Ruthazer, 2018). 
In this issue of Brain, Behavior, and Immunity, Labrousse et al. (2018) examined the 
effects of n-3 PUFAs dietary intake during pregnancy and lactation on the consequences of a 
LPS model of MIA on brain development. This is the first study to show n-3 PUFAs 
deficiency as a risk factor for the development of cognitive impairment in the offspring in the 
context of MIA. The present study is also the first to examine the effects of n-3 deficiency on 
the brain lipid composition and inflammation in MIA-exposed animals and their offspring. In 
the present study, the female mice had MIA triggered by the intraperitoneal administration of 
LPS at G17 (17 days after mating). The female mice were either fed n-3 deficient diet or n-3 
balanced diet across gestation and lactation to modulate n-3/n-6 PUFAs in the offspring. The 
present study generated 4 cohorts of mice, cohort 1 was used for the assessment of memory 
performances, cohort 2 was used for the quantification of fatty acid levels and cytokines, 
cohort 3 was used for the Fluorescence-activated cell sorting (FACS) analysis, cohort 4 was 
used to assess the cFOS expression (or neuronal activation) and measure the fatty 
composition of adult livers and brainstems. The memory tests including the spatial 
recognition and the novel object recognition were assessed at 3 months-old.  
In the present study, n-3 PUFAs deficiency exacerbates the MIA-induced n-3 PUFAs-
level decrease and increases the interleukin-6 (IL-6) production in maternal blood, placenta 
and fetal brain. Moreover, IL-6 production and DHA levels are anti-correlated in the fetal 
brain, while DHA affects the brain in a region-specific manner, particularly the hippocampus. 
In addition, n-3 deficiency has been associated with decreased neuronal activation in the 
dental gyrus of the MIA-exposed animals, and hippocampal-dependent spatial memory 
deficits in the adult offspring.  
The findings of the present study may help shed some light on the answer to the 
question of whether mandatory dosages of n-3 PUFAs supplementation for mothers during 
pregnancy should be implemented. The present study not only addresses the importance of 
deleterious effects of maternal n-3 PUFAs deficiency on the brain development of the 
offspring in the context of MIA, but further supports the action of n-3 PUFAs on cognitive 
function may be via modulation of cytokine production without affecting microglial 
phenotype. Clinical study showed that mothers with prenatal depression have a higher level 
of inflammation and a lower level of n-3 PUFAs than mothers without perinatal depression 
(Chang, Lin, et al., 2018), and n-3 PUFAs supplementation has been shown to improve 
prenatal depression (Su et al., 2008). The present study further emphasized the importance of 
having ‘enough’ n-3 PUFAs during pregnancy in mothers who are prone to immune 
activation, including perinatal depression. Of note, perinatal period is a critical window for n-
3 PUFAs on brain development, where the build-up of n-3 PUFAs during this period will 
significantly affect later cellular and behavioral activities, especially when there are other 
environmental adversities.  
  
 Conflict of Interest 
None 
 
Acknowledgments 
Dr. Chang is supported by the following grants: 104-2314-B-039-050-MY3, 103-2320-B-
039-036, from Ministry of Science and Technology, Taiwan. 
 
  
Reference 
Calder, P. C. (2005). Polyunsaturated fatty acids and inflammation. Biochem Soc Trans, 33(Pt 
2), 423-427. doi:10.1042/BST0330423 
Calder, P. C. (2006). n-3 polyunsaturated fatty acids, inflammation, and inflammatory 
diseases. Am J Clin Nutr, 83(6 Suppl), 1505S-1519S. doi:10.1093/ajcn/83.6.1505S 
Chang, J. P., Lin, C. Y., Lin, P. Y., Shih, Y. H., Chiu, T. H., Ho, M., . . . Su, K. P. (2018). 
Polyunsaturated fatty acids and inflammatory markers in major depressive episodes 
during pregnancy. Prog Neuropsychopharmacol Biol Psychiatry, 80(Pt C), 273-278. 
doi:10.1016/j.pnpbp.2017.05.008 
Chang, J. P., Su, K. P., Mondelli, V., & Pariante, C. M. (2018). Omega-3 Polyunsaturated 
Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder: a Systematic 
Review and Meta-Analysis of Clinical Trials and Biological Studies. 
Neuropsychopharmacology, 43(3), 534-545. doi:10.1038/npp.2017.160 
Estes, M. L., & McAllister, A. K. (2016). Maternal immune activation: Implications for 
neuropsychiatric disorders. Science, 353(6301), 772-777. 
doi:10.1126/science.aag3194 
Hibbeln, J. R., Davis, J. M., Steer, C., Emmett, P., Rogers, I., Williams, C., & Golding, J. 
(2007). Maternal seafood consumption in pregnancy and neurodevelopmental 
outcomes in childhood (ALSPAC study): an observational cohort study. Lancet, 
369(9561), 578-585. doi:10.1016/S0140-6736(07)60277-3 
Kingston, D., Kehler, H., Austin, M. P., Mughal, M. K., Wajid, A., Vermeyden, L., . . . Giallo, 
R. (2018). Trajectories of maternal depressive symptoms during pregnancy and the 
first 12 months postpartum and child externalizing and internalizing behavior at three 
years. PLoS One, 13(4), e0195365. doi:10.1371/journal.pone.0195365 
Labrousse, V. F., Leyrolle, Q., Amadieu, C., Aubert, A., Sere, A., Coutureau, E., . . . Laye, S. 
(2018). Dietary omega-3 deficiency exacerbates inflammation and reveals spatial 
memory deficits in mice exposed to lipopolysaccharide during gestation. Brain Behav 
Immun. doi:10.1016/j.bbi.2018.06.004 
Madore, C., Nadjar, A., Delpech, J. C., Sere, A., Aubert, A., Portal, C., . . . Laye, S. (2014). 
Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune 
system and neuronal plasticity-associated genes. Brain Behav Immun, 41, 22-31. 
doi:10.1016/j.bbi.2014.03.021 
Maekawa, M., Watanabe, A., Iwayama, Y., Kimura, T., Hamazaki, K., Balan, S., . . . 
Yoshikawa, T. (2017). Polyunsaturated fatty acid deficiency during neurodevelopment 
in mice models the prodromal state of schizophrenia through epigenetic changes in 
nuclear receptor genes. Transl Psychiatry, 7(9), e1229. doi:10.1038/tp.2017.182 
Mazahery, H., Stonehouse, W., Delshad, M., Kruger, M. C., Conlon, C. A., Beck, K. L., & 
von Hurst, P. R. (2017). Relationship between Long Chain n-3 Polyunsaturated Fatty 
Acids and Autism Spectrum Disorder: Systematic Review and Meta-Analysis of 
Case-Control and Randomised Controlled Trials. Nutrients, 9(2). 
doi:10.3390/nu9020155 
Patterson, P. H. (2009). Immune involvement in schizophrenia and autism: etiology, 
pathology and animal models. Behav Brain Res, 204(2), 313-321. 
doi:10.1016/j.bbr.2008.12.016 
Plant, D. T., Pariante, C. M., Sharp, D., & Pawlby, S. (2015). Maternal depression during 
pregnancy and offspring depression in adulthood: role of child maltreatment. Br J 
Psychiatry, 207(3), 213-220. doi:10.1192/bjp.bp.114.156620 
Solek, C. M., Farooqi, N., Verly, M., Lim, T. K., & Ruthazer, E. S. (2018). Maternal immune 
activation in neurodevelopmental disorders. Dev Dyn, 247(4), 588-619. 
doi:10.1002/dvdy.24612 
Spann, M. N., Monk, C., Scheinost, D., & Peterson, B. S. (2018). Maternal Immune 
Activation During the Third Trimester Is Associated with Neonatal Functional 
Connectivity of the Salience Network and Fetal to Toddler Behavior. J Neurosci, 
38(11), 2877-2886. doi:10.1523/JNEUROSCI.2272-17.2018 
Su, K. P., Huang, S. Y., Chiu, T. H., Huang, K. C., Huang, C. L., Chang, H. C., & Pariante, C. 
M. (2008). Omega-3 fatty acids for major depressive disorder during pregnancy: 
results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry, 
69(4), 644-651.  
 
